A Win For Myovant Sciences Ltd.
Tue, Nov 19, 2019 at 05:30 PM
Myovant Sciences Ltd. (MYOV:NYSE) soared today at $12.92, representing a gain of 113.2%. On Mon, 18 Nov 19, MYOV:NYSE hit a New 2-Week Intraday High of $6.34. The stock appeared on our News Catalysts scanner on Tue, 19 Nov 19 at 02:26 PM. From Tue, 29 Oct 19, the stock recorded 57.14% Up Days and 60.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About Myovant Sciences Ltd. (MYOV:NYSE)
Myovant Sciences Ltd is a clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing therapies for women's health diseases and other endocrine-related disorders. Its product candidate is relugolix.
Top 10 Gainers:
- Myovant Sciences Ltd. (MYOV:NYSE), 113.2%
- SAExploration Holdings, Inc. (SAEX:NASDAQ), 80.92%
- Genprex, Inc. (GNPX:NASDAQ), 48.93%
- Athenex, Inc. (ATNX:NASDAQ), 35.66%
- Agile Therapeutics, Inc. (AGRX:NASDAQ), 29.2%
- Karuna Therapeutics, Inc. (KRTX:NASDAQ), 29.16%
- Cabaletta Bio, Inc. (CABA:NASDAQ), 28.43%
- Heat Biologics, Inc. (HTBX:NASDAQ), 26.22%
- Avinger, Inc. (AVGR:NASDAQ), 25.49%
- Fulcrum Therapeutics, Inc. (FULC:NASDAQ), 25.03%